GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » La Jolla Pharmaceutical Co (NAS:LJPC) » Definitions » E10

La Jolla Pharmaceutical Co (La Jolla Pharmaceutical Co) E10 : $-9.89 (As of Jun. 2022)


View and export this data going back to 1994. Start your Free Trial

What is La Jolla Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

La Jolla Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2022 was $0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-9.89 for the trailing ten years ended in Jun. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), La Jolla Pharmaceutical Co's current stock price is $6.22. La Jolla Pharmaceutical Co's E10 for the quarter that ended in Jun. 2022 was $-9.89. La Jolla Pharmaceutical Co's Shiller PE Ratio of today is .


La Jolla Pharmaceutical Co E10 Historical Data

The historical data trend for La Jolla Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

La Jolla Pharmaceutical Co E10 Chart

La Jolla Pharmaceutical Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -85,905.70 -15,440.30 -7,183.16 -4,108.39 -13.15

La Jolla Pharmaceutical Co Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.16 -106.86 -13.15 - -9.89

Competitive Comparison of La Jolla Pharmaceutical Co's E10

For the Biotechnology subindustry, La Jolla Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


La Jolla Pharmaceutical Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, La Jolla Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where La Jolla Pharmaceutical Co's Shiller PE Ratio falls into.



La Jolla Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, La Jolla Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=0.08/125.0168*125.0168
=0.080

Current CPI (Jun. 2022) = 125.0168.

La Jolla Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201209 -9.000 97.633 -11.524
201212 -14.270 96.871 -18.416
201303 -12.260 98.209 -15.607
201306 -6.770 98.518 -8.591
201309 -5.450 98.790 -6.897
201312 -1.452 98.326 -1.846
201403 -0.930 99.695 -1.166
201406 -0.530 100.560 -0.659
201409 -0.370 100.428 -0.461
201412 -0.450 99.070 -0.568
201503 -0.590 99.621 -0.740
201506 -0.700 100.684 -0.869
201509 -0.700 100.392 -0.872
201512 -0.690 99.792 -0.864
201603 -0.960 100.470 -1.195
201606 -0.900 101.688 -1.106
201609 -1.230 101.861 -1.510
201612 -1.440 101.863 -1.767
201703 -1.260 102.862 -1.531
201706 -1.210 103.349 -1.464
201709 -1.190 104.136 -1.429
201712 -1.760 104.011 -2.115
201803 -2.220 105.290 -2.636
201806 -2.020 106.317 -2.375
201809 -1.930 106.507 -2.265
201812 -1.730 105.998 -2.040
201903 -1.170 107.251 -1.364
201906 -1.120 108.070 -1.296
201909 -1.080 108.329 -1.246
201912 -0.930 108.420 -1.072
202003 -0.320 108.902 -0.367
202006 -0.570 108.767 -0.655
202009 -0.430 109.815 -0.490
202012 -0.120 109.897 -0.137
202103 0.420 111.754 0.470
202106 0.110 114.631 0.120
202109 -0.080 115.734 -0.086
202112 0.120 117.630 0.128
202203 0.000 121.301 0.000
202206 0.080 125.017 0.080

Add all the adjusted EPS together and divide 10 will get our e10.


La Jolla Pharmaceutical Co  (NAS:LJPC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


La Jolla Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of La Jolla Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


La Jolla Pharmaceutical Co (La Jolla Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
201 Jones Road, Suite 400, Waltham, MA, USA, 02451
La Jolla Pharmaceutical Co is a biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.
Executives
Larry G. Edwards director, officer: Chief Executive Officer C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
David A Ramsay director HALOZYME THERAPEUTICS, INC., 11588 SORRENTO VALLEY ROAD, #17, SAN DIEGO CA 92121
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Kevin C Tang director, 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Darryl Wellinghoff officer: Chief Commercial Officer 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Lakhmir S Chawla officer: Chief Medical Officer 1960 KIRBY ROAD, MCLEAN VA 22101
Jennifer Carver officer: Sr. Vice President, Operations 725 NEWPORT STREET, DENVER CO 80220
James Rolke officer: Chief Scientific Officer 10182 TELESIS COURT, 6TH FLOOR, SAN DIEGO CA 92121
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
George F Tidmarsh director, officer: President, CEO & Secretary

La Jolla Pharmaceutical Co (La Jolla Pharmaceutical Co) Headlines

From GuruFocus

Innoviva to Acquire La Jolla Pharmaceutical Company

By Business Wire Business Wire 07-11-2022